流通市值:306.65亿 | 总市值:308.91亿 | ||
流通股本:51.54亿 | 总股本:51.92亿 |
报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
公司类型 | 通用 | 通用 | 通用 | 通用 |
一、经营活动产生的现金流量: | ||||
销售商品、提供劳务收到的现金 | 170,692,018,517.33 | 679,441,311,301.62 | 553,535,399,494.46 | 367,439,229,824.47 |
收到的税费返还 | 432,188,970.42 | 1,178,504,714.25 | 891,158,240.84 | 593,827,213.19 |
收到其他与经营活动有关的现金 | 4,701,790,187.13 | 2,633,551,878.8 | 8,840,909,136.85 | 5,028,346,340.06 |
经营活动现金流入的平衡项目 | 0 | 0 | 0 | 0 |
经营活动现金流入小计 | 175,825,997,674.88 | 683,253,367,894.67 | 563,267,466,872.15 | 373,061,403,377.72 |
购买商品、接受劳务支付的现金 | 175,768,321,810.16 | 661,329,116,774.55 | 546,314,360,560.9 | 363,975,978,177.57 |
支付给职工以及为职工支付的现金 | 2,126,325,186.31 | 5,916,531,907.88 | 4,374,165,107.44 | 3,260,728,689.7 |
支付的各项税费 | 1,189,677,250.23 | 3,786,829,988.41 | 3,276,260,977.38 | 2,499,014,181.56 |
支付其他与经营活动有关的现金 | 4,566,148,246.57 | 8,072,210,026.82 | 10,579,711,675.29 | 9,588,767,876.66 |
经营活动现金流出的平衡项目 | 0 | -0.01 | 0 | 0 |
经营活动现金流出小计 | 183,650,472,493.27 | 679,104,688,697.65 | 564,544,498,321.01 | 379,324,488,925.49 |
经营活动产生的现金流量净额平衡项目 | 0 | 0 | 0 | 0 |
经营活动产生的现金流量净额 | -7,824,474,818.39 | 4,148,679,197.02 | -1,277,031,448.86 | -6,263,085,547.77 |
二、投资活动产生的现金流量: | ||||
收回投资收到的现金 | 3,588,904,690.43 | 11,636,795,957.63 | 15,261,149,166.64 | 9,446,877,664.72 |
取得投资收益收到的现金 | 208,191,868.06 | 2,710,646,849.8 | 719,270,078.41 | 377,761,304.93 |
处置固定资产、无形资产和其他长期资产收回的现金净额 | 77,450,607.8 | 1,223,540,861.15 | 409,552,380.7 | 158,843,331.75 |
处置子公司及其他营业单位收到的现金净额 | 24,801,754.26 | 14,235,517.46 | 17,470,652.72 | 14,235,517.46 |
收到的其他与投资活动有关的现金 | 540,831,512.69 | 1,022,293,790.47 | 2,556,502,472.83 | 541,470,199.38 |
投资活动现金流入的平衡项目 | 0 | 0 | 0 | 0 |
投资活动现金流入小计 | 4,440,180,433.24 | 16,607,512,976.51 | 18,963,944,751.3 | 10,539,188,018.24 |
购建固定资产、无形资产和其他长期资产支付的现金 | 419,638,409.12 | 3,267,201,766.99 | 1,622,193,603.76 | 1,096,273,804.89 |
投资支付的现金 | 3,005,491,538.75 | 13,000,900,303.65 | 16,149,549,190.56 | 10,637,945,455.62 |
取得子公司及其他营业单位支付的现金 | 479,678,306.42 | 29,743,048.6 | 262,118,142.89 | 13,737,000 |
支付其他与投资活动有关的现金 | 1,893,339,000.59 | - | 3,721,752,154.45 | 622,528,734.69 |
投资活动现金流出的平衡项目 | 0 | 0 | 0 | 0 |
投资活动现金流出小计 | 5,798,147,254.88 | 16,297,845,119.24 | 21,755,613,091.66 | 12,370,484,995.2 |
投资活动产生的现金流量净额平衡项目 | 0 | 0 | 0 | 0 |
投资活动产生的现金流量净额 | -1,357,966,821.64 | 309,667,857.27 | -2,791,668,340.36 | -1,831,296,976.96 |
三、筹资活动产生的现金流量: | ||||
吸收投资收到的现金 | - | 2,202,168,041 | 2,206,660,000 | 128,360,000 |
其中:子公司吸收少数股东投资收到的现金 | - | 203,368,041 | 207,860,000 | 128,360,000 |
取得借款收到的现金 | 49,060,374,344.96 | 168,526,219,079.68 | 148,898,040,175.39 | 106,463,512,079.48 |
收到其他与筹资活动有关的现金 | 1,886,285,683.62 | 699,251,395.42 | 2,811,147,944.62 | 36,801,900 |
筹资活动现金流入平衡项目 | 0 | 0 | 0 | 0 |
筹资活动现金流入小计 | 50,946,660,028.58 | 171,427,638,516.1 | 153,915,848,120.01 | 106,628,673,979.48 |
偿还债务支付的现金 | 37,560,294,652.49 | 168,419,944,436.61 | 138,483,981,890.57 | 92,823,724,060.66 |
分配股利、利润或偿付利息支付的现金 | 455,294,188.46 | 3,386,200,963.52 | 3,469,649,014.33 | 1,609,433,242.57 |
其中:子公司支付给少数股东的股利、利润 | - | 865,089,344.38 | 850,943,641.26 | 501,880,872.95 |
支付其他与筹资活动有关的现金 | 2,410,105,709.61 | 2,398,092,011.62 | 5,249,105,343.78 | 797,714,723.38 |
筹资活动现金流出平衡项目 | 0 | 0 | 0 | 0 |
筹资活动现金流出小计 | 40,425,694,550.56 | 174,204,237,411.75 | 147,202,736,248.68 | 95,230,872,026.61 |
筹资活动产生的现金流量净额平衡项目 | 0 | 0 | 0 | 0 |
筹资活动产生的现金流量净额 | 10,520,965,478.02 | -2,776,598,895.65 | 6,713,111,871.33 | 11,397,801,952.87 |
四、汇率变动对现金及现金等价物的影响 | 4,447,087.06 | 23,299,532.65 | -115,822,006.02 | -60,099,981.97 |
现金及现金等价物净增加额平衡项目 | 0 | 0 | 0 | 0 |
五、现金及现金等价物净增加额 | 1,342,970,925.05 | 1,705,047,691.29 | 2,528,590,076.09 | 3,243,319,446.17 |
加:期初现金及现金等价物余额 | 12,556,649,229.7 | 10,851,601,538.41 | 10,851,601,538.41 | 10,851,601,538.41 |
期末现金及现金等价物余额平衡项目 | 0 | 0 | 0 | 0 |
期末现金及现金等价物余额 | 13,899,620,154.75 | 12,556,649,229.7 | 13,380,191,614.5 | 14,094,920,984.58 |
补充资料: | ||||
净利润 | - | 4,977,991,035.35 | - | 2,515,974,248.52 |
资产减值准备 | - | 931,352,291.19 | - | 969,570,271.71 |
固定资产和投资性房地产折旧 | - | 1,695,169,856.86 | - | 720,835,306 |
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧 | - | 1,695,169,856.86 | - | 720,835,306 |
无形资产摊销 | - | 269,373,179.4 | - | 132,340,509.36 |
长期待摊费用摊销 | - | 190,554,401.6 | - | 78,918,925.55 |
处置固定资产、无形资产和其他长期资产的损失 | - | -368,814,834.93 | - | -155,547,927.66 |
固定资产报废损失 | - | 2,206,618.59 | - | 789,968.96 |
公允价值变动损失 | - | -321,175,925.96 | - | -395,620,984.08 |
财务费用 | - | 1,484,236,815.36 | - | 969,395,037.21 |
投资损失 | - | -2,549,628,150.18 | - | -783,902,487.71 |
递延所得税 | - | -82,869,633.59 | - | 1,408,899.18 |
其中:递延所得税资产减少 | - | -23,196,088.92 | - | -58,133,343.73 |
递延所得税负债增加 | - | -59,673,544.67 | - | 59,542,242.91 |
存货的减少 | - | -1,258,935,379.79 | - | -17,810,754,493.3 |
经营性应收项目的减少 | - | -5,049,318,647.23 | - | -22,599,324,128.52 |
经营性应付项目的增加 | - | 3,987,642,971.65 | - | 29,974,448,766.99 |
不涉及现金收支的投资和筹资活动金额其他项目 | - | 673,168,904.61 | - | - |
现金的期末余额 | - | 12,556,649,229.7 | - | 14,094,920,984.58 |
减:现金的期初余额 | - | 10,851,601,538.41 | - | 10,851,601,538.41 |
公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-29 | 2024-08-27 |
审计意见(境内) | 标准无保留意见 |